These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23894004)

  • 1. Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism.
    Oblak A; Gibbs TT; Blatt GJ
    Autism Res; 2013 Dec; 6(6):571-83. PubMed ID: 23894004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential serotonin transporter (5-HTT) and 5-HT
    Brandenburg C; Blatt GJ
    J Neurochem; 2019 Dec; 151(5):642-655. PubMed ID: 31325179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism.
    Oblak AL; Gibbs TT; Blatt GJ
    Brain Res; 2011 Mar; 1380():218-28. PubMed ID: 20858465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
    Varnäs K; Halldin C; Hall H
    Hum Brain Mapp; 2004 Jul; 22(3):246-60. PubMed ID: 15195291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism.
    Oblak AL; Gibbs TT; Blatt GJ
    J Neurochem; 2010 Sep; 114(5):1414-23. PubMed ID: 20557420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors.
    Azmitia EC; Singh JS; Whitaker-Azmitia PM
    Neuropharmacology; 2011 Jun; 60(7-8):1347-54. PubMed ID: 21329710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and pharmacogenetics of aggressive behavior.
    Takahashi A; Quadros IM; de Almeida RM; Miczek KA
    Curr Top Behav Neurosci; 2012; 12():73-138. PubMed ID: 22297576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism.
    Oblak AL; Rosene DL; Kemper TL; Bauman ML; Blatt GJ
    Autism Res; 2011 Jun; 4(3):200-11. PubMed ID: 21360830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
    Nakamura K; Sekine Y; Ouchi Y; Tsujii M; Yoshikawa E; Futatsubashi M; Tsuchiya KJ; Sugihara G; Iwata Y; Suzuki K; Matsuzaki H; Suda S; Sugiyama T; Takei N; Mori N
    Arch Gen Psychiatry; 2010 Jan; 67(1):59-68. PubMed ID: 20048223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation.
    Valdez M; Burke TF; Hensler JG
    Brain Res; 2002 Dec; 957(1):174-82. PubMed ID: 12443993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain serotonin system in autism.
    Rodnyy AY; Kondaurova EM; Tsybko AS; Popova NK; Kudlay DA; Naumenko VS
    Rev Neurosci; 2024 Jan; 35(1):1-20. PubMed ID: 37415576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.
    Dohn MR; Kooker CG; Bastarache L; Jessen T; Rinaldi C; Varney S; Mazalouskas MD; Pan H; Oliver KH; Velez Edwards DR; Sutcliffe JS; Denny JC; Carneiro AMD
    J Neurosci; 2017 Nov; 37(46):11271-11284. PubMed ID: 29038237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.
    Saunders C; Siuta M; Robertson SD; Davis AR; Sauer J; Matthies HJG; Gresch PJ; Airey D; Lindsley CW; Schetz JA; Niswender KD; Veenstra-Vanderweele JM; Galli A
    Neurochem Int; 2014 Jul; 73():113-121. PubMed ID: 24090638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
    Li Q; Wichems C; Heils A; Lesch KP; Murphy DL
    J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims.
    Pandey GN; Dwivedi Y; Rizavi HS; Ren X; Pandey SC; Pesold C; Roberts RC; Conley RR; Tamminga CA
    Am J Psychiatry; 2002 Mar; 159(3):419-29. PubMed ID: 11870006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors.
    Ase AR; Amdiss F; Hébert C; Huang N; van Gelder NM; Reader TA
    J Neural Transm (Vienna); 1999; 106(1):75-105. PubMed ID: 10195336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.
    Takahashi A; Quadros IM; de Almeida RM; Miczek KA
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):183-212. PubMed ID: 20938650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter gene promoter polymorphism and autism: a family-based genetic association study in Japanese population.
    Koishi S; Yamamoto K; Matsumoto H; Koishi S; Enseki Y; Oya A; Asakura A; Aoki Y; Atsumi M; Iga T; Inomata J; Inoko H; Sasaki T; Nanba E; Kato N; Ishii T; Yamazaki K
    Brain Dev; 2006 May; 28(4):257-60. PubMed ID: 16481140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.
    Garbarino VR; Gilman TL; Daws LC; Gould GG
    Pharmacol Res; 2019 Feb; 140():85-99. PubMed ID: 30009933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.